Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Brough

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Cancer Research|October 23, 2022
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor ResistanceMarta J Llorca-Cardenosa, Lauren I Aronson, Dragomir B Krastev, et al.
Iscience|June 29, 2026
Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cellsJaume Barcelo, Yumiko Teigen, Joshua Alexander James Martin, et al.
Cell Reports|March 8, 2016
Large-Scale Profiling of Kinase Dependencies in Cancer Cell LinesJames Campbell, Colm J Ryan, Rachel Brough, et al.
Cancer Discovery|October 11, 2011
Functional viability profiles of breast cancerRachel Brough, Jessica R Frankum, David Sims, et al.
Cell Reports|May 10, 2023
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cellsAnabel Zelceski, Paola Francica, Lea Lingg, et al.
Molecular Cell|December 17, 2020
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRDGraeme Hewitt, Valerie Borel, Sandra Segura-Bayona, et al.
Nature Communications|July 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancersRoman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki, et al.
Oncogene|February 12, 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinomaJames Stewart, Dragomir B Krastev, Rachel Brough, et al.
Cancer Discovery|October 31, 2018
Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for SurvivalMatthew G Oser, Raquel Fonseca, Abhishek A Chakraborty, et al.
Cancer Discovery|April 4, 2018
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast CancerIlirjana Bajrami, Rebecca Marlow, Marieke van de Ven, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Cancer Research|October 23, 2022
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor ResistanceMarta J Llorca-Cardenosa, Lauren I Aronson, Dragomir B Krastev, et al.
Iscience|June 29, 2026
Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cellsJaume Barcelo, Yumiko Teigen, Joshua Alexander James Martin, et al.
Cell Reports|March 8, 2016
Large-Scale Profiling of Kinase Dependencies in Cancer Cell LinesJames Campbell, Colm J Ryan, Rachel Brough, et al.
Cancer Discovery|October 11, 2011
Functional viability profiles of breast cancerRachel Brough, Jessica R Frankum, David Sims, et al.
Cell Reports|May 10, 2023
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cellsAnabel Zelceski, Paola Francica, Lea Lingg, et al.
Molecular Cell|December 17, 2020
Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRDGraeme Hewitt, Valerie Borel, Sandra Segura-Bayona, et al.
Nature Communications|July 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancersRoman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki, et al.
Oncogene|February 12, 2025
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinomaJames Stewart, Dragomir B Krastev, Rachel Brough, et al.
Cancer Discovery|October 31, 2018
Cells Lacking the <i>RB1</i> Tumor Suppressor Gene Are Hyperdependent on Aurora B Kinase for SurvivalMatthew G Oser, Raquel Fonseca, Abhishek A Chakraborty, et al.
Cancer Discovery|April 4, 2018
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast CancerIlirjana Bajrami, Rebecca Marlow, Marieke van de Ven, et al.
Pageof 7